Ebrahim Naimi, Ph.D. - Publications

Affiliations: 
2003 University of Alberta, Edmonton, Alberta, Canada 
Area:
Pharmaceutical Chemistry, Pharmacology

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Sun W, Falzon C, Naimi E, Akbari A, Wiebe LI, Tandon M, Kumar P. Synthesis of [18F]FAZA using Nosyl and Iodo Precursors for Nucleophilic Radiofluorination. Current Radiopharmaceuticals. PMID 30338747 DOI: 10.2174/1874471011666181019105947  0.533
2017 Kumar P, Roselt P, Reischl G, Cullinane C, Beiki D, Ehrlichmann W, Binns D, Naimi E, Yang J, Hicks R, Machulla HJ, Wiebe LI. β-[18F]Fluoro Azomycin Arabinoside (β-[18F]FAZA): Synthesis, radiofluorination and preliminary PET imaging of murine A431 tumors. Current Radiopharmaceuticals. PMID 28294075 DOI: 10.2174/1874471010666170313120540  0.52
2010 Kumar P, Naimi E, McEwan AJ, Wiebe LI. Synthesis, radiofluorination, and hypoxia-selective studies of FRAZ: A configurational and positional analogue of the clinical hypoxia marker, [18F]-FAZA. Bioorganic & Medicinal Chemistry. 18: 2255-64. PMID 20181485 DOI: 10.1016/j.bmc.2010.01.064  0.51
2005 Naimi E, Kumar P, McEwan AJ, Wiebe LI. A one-pot synthesis of 1-alpha- and 1-beta-D-arabinofuranosyl-2-nitroimidazoles: synthons to the markers of tumor hypoxia. Nucleosides, Nucleotides & Nucleic Acids. 24: 173-8. PMID 15892256 DOI: 10.1081/Ncn-55700  0.494
2004 Al-Madhoun AS, Eriksson S, Wang ZX, Naimi E, Knaus EE, Wiebe LI. Phosphorylation of isocarbostyril- and difluorophenyl-nucleoside thymidine mimics by the human deoxynucleoside kinases. Nucleosides, Nucleotides & Nucleic Acids. 23: 1865-74. PMID 15628745 DOI: 10.1081/Ncn-200040634  0.498
2003 Khalili P, Naimi E, Sun WY, Knaus EE, Wiebe LI. Dose-dependent pharmacokinetics of 1(2-deoxy-β-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene: A potential mimic of 5-iodo-2′-deoxyuridine Biopharmaceutics and Drug Disposition. 24: 385-395. PMID 14689467 DOI: 10.1002/Bdd.375  0.457
2003 Khalili P, Naimi E, Sun WY, Knaus EE, Wiebe LI. Biochemical and pharmacokinetic evaluation of a novel pyrimidine nucleoside nitric oxide donor as a potential anticancer/antiviral agent European Journal of Pharmaceutical Sciences. 19: 305-313. PMID 12885396 DOI: 10.1016/S0928-0987(03)00132-5  0.52
2003 Naimi E, Zhou A, Khalili P, Wiebe LI, Balzarini J, De Clercq E, Knaus EE. Synthesis of 3′- and 5′-nitrooxy pyrimidine nucleoside nitrate esters: "Nitric oxide donor" agents for evaluation as anticancer and antiviral agents Journal of Medicinal Chemistry. 46: 995-1004. PMID 12620076 DOI: 10.1021/Jm020299R  0.557
2002 Nanda D, de Jong M, Vogels R, Havenga M, Driesse M, Bakker W, Bijster M, Avezaat C, Cox P, Morin K, Naimi E, Knaus E, Wiebe L, Smitt PS. Imaging expression of adenoviral HSV1-tk suicide gene transfer using the nucleoside analogue FIRU. European Journal of Nuclear Medicine and Molecular Imaging. 29: 939-47. PMID 12212546 DOI: 10.1007/S00259-002-0839-9  0.509
2002 Khalili P, Naimi E, Knaus EE, Wiebe LI. Pharmacokinetics and metabolism of the novel synthetic C-nucleoside, 1-(2-deoxy-β-D-ribofuranosyl)-2,4-difluoro-5-iodobenzene: A potential mimic of 5-iodo-2′-deoxyuridine Biopharmaceutics and Drug Disposition. 23: 105-113. PMID 12173545 DOI: 10.1002/Bdd.301  0.554
2001 Naimi E, Duan W, Wiebe LI, Knaus EE. Synthesis of unnatural 7-substituted-1-(2-deoxy-beta-D-ribofuranosyl)isocarbostyrils: "thymine replacement" analogs of deoxythymidine for evaluation as antiviral and anticancer agents. Nucleosides, Nucleotides & Nucleic Acids. 20: 1533-53. PMID 11554544 DOI: 10.1081/Ncn-100105246  0.529
2001 Naimi E, Wiebe LI, Balzarini J, De Clercq E, Knaus EE. Synthesis of 1-(2-deoxy-?-D-ribofuranosyl)-2,4- difluoro-5-(2-halo-1-hydroxyethyl)benzenes and related derivatives: ?thymine replacement? analogs of deoxythymidine for evaluation as antiviral and anticancer agents Drug Development Research. 52: 492-499. DOI: 10.1002/Ddr.1151  0.543
Show low-probability matches.